| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |